Ned will speak InspireSci on Oct 26th- “Improvising in Science and Jazz".

Therapeutic monoclonal antibodies are unable to neutralize Omicron BA.2. Check out our preprint ! biorxiv.org/content/10.110…

CORRECTION: The data in preprint on #omicronba2 used an incorrect BA.2 spike protein that contained additional mutations. The data on evasion of mAbs by BA.2 are incorrect. Expts will be repeated and manuscript corrected ASAP. We apologize for the error.

Dr. Landau spoke with medical news today about #Moderna 's bivalent #vaccine #COVID19 medicalnewstoday.com/articles/moder…

Ned speaks with the gothamist (WNYC) about #Omicron variant. gothamist.com/news/cuny-only…

We love it when our famous senior postdoc, Takuya Tada, returns from #Japan with rather cute presents! The Landau Lab Academic Chatter™ NYU Langone Health

Dr Landau Speaks to NPR Goats & Soda about #COVID19 superdodgers npr.org/sections/goats…

Catch Ned on the NPR morning edition speaking about #HIV and #COVID #superdogers npr.org/2022/09/28/112…

when Ned (The Landau Lab ) is not working on HIV-1 or COVID, he is playing music with the locals on the streets of Rome...priceless

Our work on ACE2 receptor decoy protein against #SARSCoV2 was published in iScience journal sciencedirect.com/science/articl…

Our latest work on vectored immunoprophylaxis providing protection against #SARSCoV2 was published in The Proceedings of the National Academy of Sciences (PNAS) pnas.org/doi/10.1073/pn…

Our latest work on single-epitope T cell vaccine against #SARSCoV2 is published in JCI Insight. Follow the link to read more... pubmed.ncbi.nlm.nih.gov/37036004/

Check out our work on lentiviral vector-based T cell vaccine against acute and chronic viral infection published on JCI Insight. pubmed.ncbi.nlm.nih.gov/35972807/

NIH research matters featured our recent work on developing decoy-expressing viral vector against SARS-CoV-2. Check the following link. nih.gov/news-events/ni…

Congratulations to Takuya Tada in Landau Lab for getting the 2023 Outstanding Postdoc Award at NYU Langone Health!

Our latest work on Checkpoint inhibitor-expressing lentiviral vector-based vaccine suppresses tumor growth in preclinical cancer models was published in Journal for ImmunoTherapy of Cancer! doi.org/10.1136/jitc-2….

Wallace Wong in our lab had a poster presentation in 50th Annual Undergraduate Research Conference! He showed that our lentiviral vector-based CAR-DCs prevented tumor growth in mouse.

Ruofan Li in our lab had a poster presentation in 50th Annual Undergraduate Research Conference! She generated CAR-DCs against tumor. She showed that CAR-DCs prevented and treated tumor in mouse model.